Skip to main content
. 2016 Nov 24;45:62. doi: 10.1186/s40463-016-0175-x

Fig. 2.

Fig. 2

Kaplan-Meier curves for (a) locoregional control, (b) progression-free survival, and (c) overall survival in patients receiving weekly carboplatin versus every-3-weeks cisplatin chemoradiation regimens. The log rank test was used to assess for differences in outcomes